Skip to content
DataLookout
Menu

Grünenthal GmbH clinical trial pipeline

Get alerts when Grünenthal GmbH's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor: Tegacorat in Male Participants 4 to <7 Years of Age With Duchenne Muscular Dystrophy Start date pushed from Nov 9, 2026 to Nov 30, 2026 Grünenthal GmbHPhase 2 NCT07911995
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-11-03 NCT07911995 A Trial to Investigate the Efficacy and Safety of Tegacorat in Male Participants 4 to <7… Phase 2 Not Yet Recruiting

Active trials by phase

Phase 1
1
Phase 2
2

Disease areas by active trials

Get alerts when Grünenthal GmbH's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free